BioLife Solutions (BLFS) to Register 10.7M Shares Related to Completed Acquisition

BioLife Solutions, Inc. (Nasdaq: BLFS) filed a registration statement on Form S-3 with the Securities and Exchange Commission ("SEC") to register approximately 10.7 million shares of restricted common stock held by stockholders of previously acquired companies Global Cooling, Inc. (operating as Stirling Ultracold), SciSafe Holdings, Inc. and Sexton Biotechnologies, Inc., as well as certain shares held by Casdin Capital. BioLife is not registering the issuance of any new shares of common stock.

"It has been very exciting and gratifying to expand our business through the acquisition of these successful and complementary companies in a growing market with significant upside opportunity," said Mike Rice, BioLife Solutions Chairman and CEO. "We are registering restricted shares of BioLife common stock in accordance with our obligations associated with these acquisitions. In addition, a component of the registration statement includes shares held by Casdin Capital, who remains a supportive and committed shareholder of BioLife as we continue to build upon our position as a leading supplier of class-defining cell and gene therapy bioproduction tools and services."

The registration statement relating to these securities has been filed with the SEC and has become effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities.

You May Also Be Interested In

• Definium Therapeutics prices $700M public offering at $34 per share
• GameStop drops Cohen’s $35B pay plan to focus on eBay acquisition
• Leifras to acquire Swift Japan childcare operator for ¥454.6 million